
Nicholas Rizzo
Examiner (ID: 13657)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1803, 1307 |
| Total Applications | 1799 |
| Issued Applications | 1459 |
| Pending Applications | 17 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7491909
[patent_doc_number] => 08030538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Cattle beta-casein gene targeting vector using homologous recombination'
[patent_app_type] => utility
[patent_app_number] => 10/574747
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 33
[patent_no_of_words] => 13518
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/030/08030538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10574747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574747 | Cattle beta-casein gene targeting vector using homologous recombination | Nov 17, 2005 | Issued |
Array
(
[id] => 4442277
[patent_doc_number] => 07928064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-19
[patent_title] => 'Transgenically produced antithrombin III'
[patent_app_type] => utility
[patent_app_number] => 11/284585
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6522
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/928/07928064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284585 | Transgenically produced antithrombin III | Nov 13, 2005 | Issued |
Array
(
[id] => 5615467
[patent_doc_number] => 20060117397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Imaging modalities for screening Alzheimer\'s disease therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/266230
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7728
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20060117397.pdf
[firstpage_image] =>[orig_patent_app_number] => 11266230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/266230 | Imaging modalities for screening Alzheimer's disease therapeutics | Nov 3, 2005 | Abandoned |
Array
(
[id] => 326487
[patent_doc_number] => 07514258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Mammalian cultured inner cell mass cell culture using a quiescent cell as nuclear'
[patent_app_type] => utility
[patent_app_number] => 11/265113
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8868
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514258.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265113 | Mammalian cultured inner cell mass cell culture using a quiescent cell as nuclear | Nov 2, 2005 | Issued |
Array
(
[id] => 5830885
[patent_doc_number] => 20060064763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Unactivated oocytes as cytoplast recipients for nuclear transfer'
[patent_app_type] => utility
[patent_app_number] => 11/265114
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6750
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20060064763.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265114 | Mammalian cultured inner cell mass cell culture using a g1 cell as nuclear donor | Nov 2, 2005 | Issued |
Array
(
[id] => 5590935
[patent_doc_number] => 20060040387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Islet cells from human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/262633
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13719
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040387.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262633 | Endoderm cells from human embryonic stem cells | Oct 30, 2005 | Issued |
Array
(
[id] => 5526783
[patent_doc_number] => 20090196860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Isolated Primate Embryonic Cells and Methods of Generating and Using Same'
[patent_app_type] => utility
[patent_app_number] => 11/665248
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18494
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196860.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665248 | Isolated primate embryonic cells derived from extended blastocysts | Oct 10, 2005 | Issued |
Array
(
[id] => 5717383
[patent_doc_number] => 20060080746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Methods of embryo transfer'
[patent_app_type] => utility
[patent_app_number] => 11/238297
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4670
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20060080746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238297
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238297 | Methods of embryo transfer | Sep 27, 2005 | Abandoned |
Array
(
[id] => 5819967
[patent_doc_number] => 20060024280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/228549
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10517
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11228549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/228549 | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5814110
[patent_doc_number] => 20060084168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Medium and culture of embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/221457
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3970
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084168.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221457 | Medium containing pipecholic acid and gamma amino butyric acid and culture of embryonic stem cells | Sep 7, 2005 | Issued |
Array
(
[id] => 5125899
[patent_doc_number] => 20070238170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Culturing human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/221516
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4473
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238170.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221516
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221516 | Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid | Sep 7, 2005 | Issued |
Array
(
[id] => 5385291
[patent_doc_number] => 20090226536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS'
[patent_app_type] => utility
[patent_app_number] => 11/574606
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18706
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226536.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574606
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574606 | METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5726959
[patent_doc_number] => 20060057719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Carbohydrate determinant selection system for homologous recombination'
[patent_app_type] => utility
[patent_app_number] => 11/219419
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16644
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219419 | Carbohydrate determinant selection system for homologous recombination | Sep 1, 2005 | Abandoned |
Array
(
[id] => 352842
[patent_doc_number] => 07491865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene'
[patent_app_type] => utility
[patent_app_number] => 11/208257
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16293
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208257
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208257 | Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene | Aug 18, 2005 | Issued |
Array
(
[id] => 8760364
[patent_doc_number] => 08420886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Transgenic mouse comprising a disrupted Fibulin-4 gene as a model for cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 11/996392
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8413
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11996392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996392 | Transgenic mouse comprising a disrupted Fibulin-4 gene as a model for cardiovascular disease | Jul 21, 2005 | Issued |
Array
(
[id] => 5212359
[patent_doc_number] => 20070250943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Construction of Chimera Using En Cells'
[patent_app_type] => utility
[patent_app_number] => 11/632896
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18386
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 47
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20070250943.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632896 | Construction of Chimera Using En Cells | Jul 19, 2005 | Abandoned |
Array
(
[id] => 4903524
[patent_doc_number] => 20080112937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Method of Producing Autologous Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 11/632860
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13779
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20080112937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632860 | Method of Producing Autologous Embryonic Stem Cells | Jul 18, 2005 | Abandoned |
Array
(
[id] => 7256912
[patent_doc_number] => 20050273870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Preparation and selection of donor cells for nuclear transplantation'
[patent_app_type] => utility
[patent_app_number] => 11/174825
[patent_app_country] => US
[patent_app_date] => 2005-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8785
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20050273870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11174825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/174825 | Preparation and selection of donor cells for nuclear transplantation | Jul 4, 2005 | Abandoned |
Array
(
[id] => 6925949
[patent_doc_number] => 20050239204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Multifunctional molecular complexes for gene transfer to cells'
[patent_app_type] => utility
[patent_app_number] => 11/170539
[patent_app_country] => US
[patent_app_date] => 2005-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31743
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239204.pdf
[firstpage_image] =>[orig_patent_app_number] => 11170539
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/170539 | Multifunctional molecular complexes for gene transfer to cells | Jun 28, 2005 | Abandoned |
Array
(
[id] => 5795275
[patent_doc_number] => 20060015956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Method to decrease the rate of polyspermy in IVF'
[patent_app_type] => utility
[patent_app_number] => 11/159758
[patent_app_country] => US
[patent_app_date] => 2005-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7026
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20060015956.pdf
[firstpage_image] =>[orig_patent_app_number] => 11159758
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/159758 | Method to decrease the rate of polyspermy in IVF | Jun 22, 2005 | Abandoned |